Abstract
Sweating deficiency has been reported to represent a cardinal symptom of ectrodactyly-ectodermal dysplasia-cleft lip/palate syndrome and ankyloblepharon-ectodermal dysplasia-cleft lip/palate syndrome, two rare p63-associated disorders. According to online resources, hypohidrosis may lead to most life-threatening complications in affected patients. Thus, counseling on the prevention of hyperthermia would be indispensable in case of such syndromes, although detailed information on this issue is missing in the literature. We investigated 14 individuals with ectrodactyly-ectodermal dysplasia-cleft lip/palate syndrome (age range 2–48 years) and 9 individuals with ankyloblepharon-ectodermal dysplasia-cleft lip/palate syndrome (0.5–60 years of age) by confocal laser scanning microscopy to determine their palmar sweat duct density and by quantification of pilocarpine-induced sweating. Genotype-phenotype correlations were assessed. In 12 of 23 patients (52%), a normal amount of sweat ducts was detected. These individuals (9 with ectrodactyly-ectodermal dysplasia-cleft lip/palate syndrome, 3 with ankyloblepharon-ectodermal dysplasia-cleft lip/palate syndrome) produced sufficient sweat volumes (≥ 20 μl) in response to pilocarpine. All other patients had clearly reduced sweating ability and fewer sweat glands, but no anhidrosis. Alteration of a specific proline residue (Pro590) of p63 was consistently linked to impaired perspiration.
Conclusion: Hypohidrosis in p63-associated syndromes is less common and potentially less severe than previously thought and may be attributable to certain genotypes.
What is Known: • Hypohidrosis which has been listed as a cardinal symptom of AEC and EEC syndromes may lead to life-threatening hyperthermia. | |
What is New: • Patients with EEC and AEC syndromes often can sweat normally. • Hypohidrosis seems to be attributed to certain TP63 genotypes. |
Avoid common mistakes on your manuscript.
Introduction
Sweating matters, particularly during summer sun exposure or intense physical activity when insufficient perspiration (hypohidrosis), may lead to heat exhaustion and heatstroke. Ectrodactyly-ectodermal dysplasia-cleft lip/palate (EEC) syndrome [OMIM 604292] and ankyloblepharon-ectodermal dysplasia-cleft lip/palate (AEC) syndrome [OMIM 106260] are very rare genetic disorders caused by mutations in the gene TP63 encoding the transcription factor p63 [1, 3]. In several textbooks, e.g., Andrews’ diseases of the skin: clinical dermatology, and online resources such as Orphanet and Wikipedia, hypohidrosis is listed as a cardinal symptom of these two p63-associated disorders. The current Orphanet entry on EEC syndrome (ORPHA1896), for example, states that hypohidrosis would lead to most life-threatening complications in affected patients. If that was true, the diagnosis of EEC or AEC syndrome would require early postnatal counseling of affected families on the prevention of overheating, as recommended and routinely provided to the parents of infants with hypohidrotic ectodermal dysplasia [6, 9]. To date, however, not many details on the sweating ability of patients with EEC or AEC syndrome have been reported in the literature.
Sweat pore densities can be estimated on graphite prints of the palm [9] provided that the staining is applied evenly across the dermal ridges. In more recent studies, reflectance confocal laser scanning microscopy has allowed more accurate determination of sweat pore densities at the palms or soles, and data from individuals with hypohidrotic ectodermal dysplasia as well as from healthy control subjects of various age groups have been collected [2, 4, 10]. Sweat gland function can be evaluated by quantification of pilocarpine-induced sweating with well-established devices [9, 10] that are used worldwide in infants for the laboratory diagnosis of cystic fibrosis [7]. To clarify whether TP63 mutations that underlie EEC or AEC syndrome are indeed associated with severe sweating deficiency, we measured number and function of sweat glands and assessed genotype-phenotype correlations in a group of individuals with known or yet unreported TP63 mutations.
Subjects and methods
Fourteen individuals with EEC syndrome between 2 and 48 years of age and 9 individuals with AEC syndrome (age range 0.5 to 60 years) were enrolled in this study conducted alongside a family conference of the German-Swiss-Austrian ectodermal dysplasia patient organization. All adult subjects gave written informed consent to participate; in the case of minors, parental consent and if possible assent of the child were obtained. The study was approved by an independent institutional ethics committee and conducted according to national regulations and GCP/ICH guidelines. Subjects were included only if pathogenic TP63 variants had been detected prior to the study and liquid intake on the day of the study had been normal. Criteria for exclusion were acute febrile illness, pregnancy, implantable electronic devices, and known plaster allergy.
The medical history of each subject was taken (including finger and toe numbers at birth, extent of orofacial clefting, and genetic data), followed by routine clinical assessments, photo-documentation of split-hand and foot malformations, and standardized evaluation of palmar sweat ducts and sweating ability.
Sweat duct imaging
Palmar sweat ducts were visualized in an area of 36 mm2 of the right hand by reflectance confocal microscopy with the VivaScope 1500 (Caliber Imaging & Diagnostics, NY). Microscopic images were evaluated by an independent experienced examiner blinded to the genotype of the subject. The sweat duct count was calculated per square centimeter. As infants—due to their smaller body surface—have a much higher sweat pore density than schoolchildren and adults, sweat duct counts were compared after being extrapolated to whole-body surface area according to the Mosteller formula.
Quantification of pilocarpine-induced sweating
Sweat was collected by a standardized procedure from an area of 57 mm2 of the right forearm for 30 min after stimulation with a pilocarpine gel disk using the Wescor 3700 device (Wescor, Logan, USA). Maximum volume that could be collected in the disposable microbore tubing spiral (Macroduct Sweat Collector) placed over the stimulated area of the skin was 93 μl. A small amount of blue dye facilitated quantification of the sweat volume in the tubing by comparison with a spiral template marked with appropriate lines.
Statistical analysis
Descriptive statistics were calculated for each group. Group comparisons between EEC/AEC patients without thermoregulation problems and EEC or AEC patients with relevant hypohidrosis were done by Mann-Whitney U test using SPSS software version 17.0 for Windows (SPSS Inc., Chicago, IL, USA).
Results
Twelve of 23 subjects with AEC or EEC syndrome investigated in this study (52%) had a medical history without thermoregulation problems, as reported by the patients themselves or by their parents, and were found to have both normal sweat pore densities at the palm and sufficient sweat production on the forearm (≥ 20 μl within 30 min) in response to stimulation with pilocarpine. None of them had ever been hospitalized for unexplained hyperthermia, and 8 practiced sports regularly at least two times per week. For 5 patients with EEC syndrome (1 male, 4 female) and 6 patients with AEC syndrome (all female), mild to moderate thermoregulation problems were reported including the occurrence of hyperthermic episodes during childhood, in the summer months, or when exercising for more than 30 min. In all 11 affected subjects, palmar sweat pore density and pilocarpine-induced sweat production were diminished, but none of these patients suffered from anhidrosis. Individual data for each subject are shown in Table 1.
Since in each case the pathogenic TP63 variant had been identified prior to the study, including six previously unreported missense mutations (Table 1), genotype-phenotype correlations with respect to number and function of sweat glands could be assessed.
Most interestingly, in-frame deletion of the serine residue at position 285 of p63 (DNA binding domain) did not cause hypohidrosis, albeit being associated with a severe split-hand phenotype (Fig. 1, upper panel). In general, there was no correlation between the severity of sweat gland maldevelopment and the extent of split-hand malformation. Subject EEC-14, for example, had all ten fingers but very few sweat glands (Fig. 1, lower panel). The three subjects with the TP63 variant p.Arg266Gln showed normal sweat duct densities and sweating ability but highly variable split-hand and foot malformation.
All patients with the TP63 missense mutation c.1028G>A (p.Arg343Gln) known to cause EEC syndrome had fewer sweat ducts and lower sweating ability than patients with upstream mutations (Table 1). Subject EEC-5 was an exception, most likely explained by the additional EDA mutation p.Arg69Leu that impairs sweat gland development [9]. In our patients with AEC syndrome, alteration of a specific proline residue (Pro590) always led to hypohidrosis, and the missense mutations c.1766T>G (p.Ile589Ser) or c.1799G>A (p.Gly600Asp) were in all cases but one associated with relatively few sweat ducts and reduced sweating ability, whereas two mutations upstream which also caused the classical phenotype of AEC syndrome did not appear to have affected sweat gland number and function.
Discussion
This study shows that hypohidrosis is rather uncommon in EEC syndrome, as stated recently also by Sutton and van Bokhoven in GeneReviews [TP63-related disorders]. However, reduced sweating ability seems to be a more frequent issue in patients with AEC syndrome, which may be due to pathogenetic differences. TP63 mutations that cause AEC syndrome are known to lead to impaired protein-protein interaction; protein aggregation of the p63 transcription factor was shown to underlie severe skin fragility in AEC syndrome [8]. Taking into account that none of our 23 patients suffered from anhidrosis and more than half could sweat normally, the importance of disturbed thermoregulation in both syndromes seems to be overestimated in current textbooks and online resources such as Orphanet.
Although for p63-associated syndromes rather strong genotype-phenotype correlations have been observed [1, 11], there are exceptions with overlapping symptoms. In this study, all but one mutations affecting the sterile alpha motif (SAM) domain of p63 resulted in AEC syndrome. Patient EEC-13 who carried a previously unreported mutation in the same region, however, displayed a distinct phenotype of EEC syndrome including split-foot malformation, extremely sparse hair, lack of eyebrows, hypoplastic nails, and severe hypohidrosis. We found no correlation between the extent of hand or foot malformation and maldevelopment of sweat glands, but identified two sites in the gene TP63, mutation of which was regularly associated with fewer sweat glands and impaired perspiration. This indicates some relevant, previously unrecognized genotype-phenotype correlation with respect to the sweating ability.
Interestingly, 10 of 11 patients with thermoregulation problems due to hypohidrosis were female. This might reflect in part the general perception that, beyond a certain requirement for heat loss, men have a larger sweat output per gland than women [5] but would be fully explained by the lower sweat gland density and sweat production observed in the affected individuals. The patients with relevant hypohidrosis also showed a tendency for higher body temperature at rest compared with those EEC/AEC patients who were able to sweat normally. Nevertheless, thermoregulation problems did not seem to affect their daily life too much and did not prevent 4 of 11 hypohidrotic patients (36%) from practicing sports at least two times per week. Although the risk of overheating therefore does not approximate that of X-linked hypohidrotic ectodermal dysplasia, we think it is reasonable and probably cost-effective to recommend confocal microscopy and/or sweat volume assessment in all infants with EEC or AEC syndrome.
Thus, hypohidrosis in EEC/AEC syndromes is less common and potentially less severe than previously thought, but a postnatal discussion with the family regarding risk of hyperthermia is still warranted. Reduced sweating ability as a facultative symptom of p63-associated disorders may be attributable to certain genotypes.
Abbreviations
- AEC:
-
Ankyloblepharon-ectodermal dysplasia-cleft lip/palate
- EEC:
-
Ectrodactyly-ectodermal dysplasia-cleft lip/palate
- SAM:
-
Sterile alpha motif
- DNA:
-
Deoxyribonucleic acid
References
Brunner HG, Hamel BC, van Bokhoven H (2002) The p63 gene in EEC and other syndromes. J Med Genet 39:377–381
Burger K, Schneider AT, Wohlfart S, Kiesewetter F, Huttner K, Johnson R, Schneider H (2014) Genotype-phenotype correlation in boys with X-linked hypohidrotic ectodermal dysplasia. Am J Med Genet Part A 164:2424–2432
Celli J, Duijf P, Hamel BC, Bamshad M, Kramer B, Smits AP, Newbury-Ecob R, Hennekam RC, van Buggenhout G, van Haeringen A, Woods CG, van Essen AJ, de Waal R, Vriend G, Haber DA, Yang A, McKeon F, Brunner HG, van Bokhoven H (1999) Heterozygous germ line mutations in the p53 homolog p63 are the cause of EEC syndrome. Cell 99:143–153
Dietz J, Kaercher T, Schneider AT, Zimmermann T, Huttner K, Johnson R, Schneider H (2013) Early respiratory and ocular involvement in X-linked hypohidrotic ectodermal dysplasia. Eur J Pediatr 172:1023–1031
Gagnon D, Kenny GP (2012) Sex difference in thermoeffector responses during exercise at fixed requirements for heat loss. J Appl Physiol 113:746–757
Hammersen JE, Neukam V, Nüsken KD, Schneider H (2011) Systematic evaluation of exertional hyperthermia in children and adolescents with hypohidrotic ectodermal dysplasia: an observational study. Pediatr Res 70:297–301
Mishra A, Greaves R, Massie J (2005) The relevance of sweat testing for the diagnosis of cystic fibrosis in the genomic era. Clin Biochem Rev 26:135–153
Russo C, Osterburg C, Sirico A, Antonini D, Ambrosio R, Würz JM, Rinnenthal J, Ferniani M, Kehrloesser S, Schäfer B, Güntert P, Sinha S, Dötsch V, Missero C (2018) Protein aggregation of the p63 transcription factor underlies severe skin fragility in AEC syndrome. Proc Natl Acad Sci U S A 115:E906–E915
Schneider H, Hammersen J, Preisler-Adams S, Huttner K, Rascher W, Bohring A (2011) Sweating ability and genotype in individuals with X-linked hypohidrotic ectodermal dysplasia. J Med Genet 48:426–432
Schneider H, Faschingbauer F, Schuepbach-Mallepell S, Körber I, Wohlfart S, Dick A, Wahlbuhl M, Kowalczyk-Quintas C, Vigolo M, Kirby N, Tannert C, Rompel O, Rascher W, Beckmann MW, Schneider P (2018) Prenatal correction of X-linked hypohidrotic ectodermal dysplasia. New Engl J Med 378:1604–1610
Tadini G, Santagada F, Brena M, Pezzani L, Nannini P (2013) Ectodermal dysplasias: the p63 tail. G Ital Dermatol Venereol 148:53–58
Acknowledgements
We would like to express our gratitude to all individuals who participated in the study.
Funding
This study was funded by the German-Swiss-Austrian ectodermal dysplasia patient organization.
Author information
Authors and Affiliations
Contributions
P.F. and H.S. conceived the study, investigated the patients, and wrote the first draft of the manuscript. Most of the work was performed by P.F. in fulfillment of the requirements for obtaining the degree “Dr. med.” from the Friedrich-Alexander-Universität Erlangen-Nürnberg. S.W. provided essential assistance with the confocal laser scanning microscopy. All authors reviewed the results and approved the final version of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Informed consent
All adult participants provided written informed consent; in the case of minors, parental consent was obtained.
Additional information
Communicated by Peter de Winter
Rights and permissions
About this article
Cite this article
Ferstl, P., Wohlfart, S. & Schneider, H. Sweating ability of patients with p63-associated syndromes. Eur J Pediatr 177, 1727–1731 (2018). https://doi.org/10.1007/s00431-018-3227-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-018-3227-6